Bristol-Myers Squibb’s merger with Celgene is done. 8 challenges ahead – STAT

Bristol-Myers Squibb’s merger with Celgene is done. 8 challenges ahead – STAT

After months of horse-trading, hand-wringing, and heated debate, the $74 billion merger of Bristol-Myers Squibb and Celgene was finally approved by shareholders on Friday. “We’re very excited about the new company,” Giovanni Caforio, Bristol’s chairman and CEO, said at the meeting. Now what? Like Dustin Hoffman and Katharine Ross in the last scene of “The…

Must Read

- Advertisement -